Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event as of January 19, 2022
The Department of Health released a department circular which includes Molnupiravir 200 mg capsule, an investigational drug for COVID-19, in the list of medicines that are under the Suggested Retail Price (SRP) in order to ensure price regulation of the drug.
The Philippine COVID-19 Living Recommendations suggest the use of molnupiravir among non-hospitalized adult patients with mild to moderate COVID-19 as infection with at least one risk factor for progression.
Read the full document to know the formulation and price of the Molnupiravir included in the SRP.
Telephone Number: 02-8757734 Loc. 253
Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City
Email Address: firstname.lastname@example.org